Floatz logo

299 assets in Lung Cancer

Therapeutic assets addressing Lung Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Brodalumab
Lung Cancer
Brian Henick, MDP1C (37)
Cadvec
Lung Cancer
Baylor College of MedicineP1C (37)
cd70-targeting car-t cells
Lung Cancer
Chongqing Precision Biotech Co., LtdP1C (37)
Cid-078 Monotherapy
Lung Cancer
Circle PharmaP1C (37)
Clsp-1025
Lung Cancer
Clasp Therapeutics, Inc.P1C (37)
Cpg-Odn
Lung Cancer
Second Affiliated Hospital of Guangzhou Medical UniversityP1C (37)
do-2
Lung Cancer
DeuterOncologyP1C (37)
Dp Cd8 Til
Lung Cancer
AgonOx, Inc.P1C (37)
Guadecitabine
Lung Cancer
Memorial Sloan Kettering Cancer CenterP1C (37)
Hbi-2438
Lung Cancer
HUYABIO International, LLC.P1C (37)
hs-10504
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
hs-20117
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
hs-20122
Lung Cancer
Hansoh BioMedical R&D CompanyP1C (37)
Idov-Immune
Lung Cancer
ViroMissile, Inc.P1C (37)
Kk-Lc-1 Tcr-T Cells
Lung Cancer
Christian HinrichsP1C (37)
Loperamide
Lung Cancer
M.D. Anderson Cancer CenterP1C (37)
Lutetium [177Lu] Bl-Arc001
Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
Mnpr-101-Dfo-89Zr
Lung Cancer
Monopar TherapeuticsP1C (37)
Mnpr-101-Pcta-177Lu
Lung Cancer
Monopar TherapeuticsP1C (37)
Phn-010
Lung Cancer
Pheon TherapeuticsP1C (37)
QXL138AM
Lung Cancer
Nammi Therapeutics IncP1C (37)
Rsc-1255
Lung Cancer
RasCal Therapeutics, Inc.P1C (37)
Sarilumab
Lung Cancer
M.D. Anderson Cancer CenterP1C (37)
Shr-1826
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
Shr-A2009
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
Shr-A2102
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
Tbi-1301
Lung Cancer
University Health Network, TorontoP1C (37)
Tcr-T Cells
Lung Cancer
Beijing DCTY Biotech Co.,Ltd.P1C (37)
Tilt-123
Lung Cancer
TILT Biotherapeutics Ltd.P1C (37)
tqb2101 for
Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.P1C (37)
Vsv-02
Lung Cancer
The First Affiliated Hospital of Xinxiang Medical CollegeP1C (37)
Wm-A1-3389
Lung Cancer
Wellmarker BioP1C (37)
Zirconium Zr 89 Crefmirlimab Berdoxam
Lung Cancer
Memorial Sloan Kettering Cancer CenterP1C (37)
ic9.gd2.car.il-15 t-cells
Lung Cancer
UNC Lineberger Comprehensive Cancer CenterEarly P1C (34)
R130
Lung Cancer
Shanghai Yunying Medical TechnologyEarly P1C (34)
Recombinant L-Ifn Adenovirus
Lung Cancer
Shanghai Fengxian District Central HospitalEarly P1C (34)
Mocetinostat
Lung Cancer
Memorial Sloan Kettering Cancer CenterP1D (30)
Tusamitamab Ravtansine
Lung Cancer
Erasmus Medical CenterP2D (29)
[18f]f-resca-epcd6
Lung Cancer
RenJi HospitalN/AD (28)
18F-WL12
Lung Cancer
Peking University Cancer Hospital & InstituteN/AD (28)
[68ga]ga-nota-epcd6
Lung Cancer
RenJi HospitalN/AD (28)
68ga-my
Lung Cancer
Peking University Cancer Hospital & InstituteN/AD (28)
68Ga-WL12
Lung Cancer
Peking University Cancer Hospital & InstituteN/AD (28)
Blood, Whole
Lung Cancer
UNC Lineberger Comprehensive Cancer CenterN/AD (28)
Copper Cu 64 Anti-Cea Monoclonal Antibody M5A
Lung Cancer
City of Hope Medical CenterN/AD (28)
Luveltamab Tazevibulin
Lung Cancer
Sutro Biopharma, Inc.P2D (27)
Fz-Ad005
Lung Cancer
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.P1NR ()
Showing 251 to 298 of 298 assets
PreviousPage 6 of 6Next